R Squared LTD Lucid Diagnostics Inc. Transaction History
R Squared LTD
- $214 Billion
- Q4 2025
A detailed history of R Squared LTD transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, R Squared LTD holds 18,439 shares of LUCD stock, worth $19,914. This represents 0.01% of its overall portfolio holdings.
Number of Shares
18,439Holding current value
$19,914% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding LUCD
# of Institutions
85Shares Held
32.9MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA4.97MShares$5.37 Million0.0% of portfolio
-
Masters Capital Management LLC Atlanta, GA4MShares$4.32 Million0.15% of portfolio
-
Abrdn PLC3.46MShares$3.73 Million0.01% of portfolio
-
Two Seas Capital LP Rye, NY3MShares$3.24 Million0.06% of portfolio
-
Awm Investment Company, Inc. New York, NY2.99MShares$3.23 Million0.37% of portfolio
About Lucid Diagnostics Inc.
- Ticker LUCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 38,568,500
- Market Cap $41.7M
- Description
- Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...